Assignee
NEXTCEA INC
US·0 granted patents·2 pending applications·0 citations·filing 2018–2022
Top patents by PatentIndex Score
2 records- 0163US2022372545A1Method for overcoming genetic resistance, enhancing therapeutic efficacy, and minimizing safety risks associated with kinase inhibitor therapyNEXTCEA INC·Filed 2022·Application pending·0 cites
- 0250US2020147070A1Inducing phospholipidosis for enhancing therapeutic efficacyNEXTCEA INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEXTCEA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →